Lipella Pharmaceuticals Inc. (NASDAQ: LIPO)
$2.4500
+0.0300 ( +1.24% ) 23.7K
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
Market Data
Open
$2.4500
Previous close
$2.4200
Volume
23.7K
Market cap
$2.93M
Day range
$2.4400 - $2.6300
52 week range
$2.2100 - $12.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 67 | Nov 14, 2024 |
| def | Proxies and info statements | 3 | Nov 12, 2024 |
| 8-k | 8K-related | 17 | Nov 07, 2024 |
| 8-k | 8K-related | 14 | Nov 01, 2024 |
| pre | Proxies and info statements | 3 | Nov 01, 2024 |
| 8-k | 8K-related | 13 | Oct 18, 2024 |
| 8-k | 8K-related | 13 | Sep 11, 2024 |
| 8-k | 8K-related | 13 | Aug 23, 2024 |
| 10-q | Quarterly Reports | 65 | Aug 13, 2024 |
| def | Proxies and info statements | 3 | Aug 12, 2024 |